The United States of American has virtually bought all stocks for the next three months of Remdesivir, one of two drugs that have been shown to be effective against COVID-19. The movement, which leaves Europe without access to this drug and more, and creates concern.
Remdesivir, the first drug approved by US and European authorities to treat COVID-19, is produced by Gilead and has been shown to be effective in recovering coronavirus patients faster.
The first 140,000 doses, provided for medical studies worldwide, have already been consumed. The Trump administration has now bought more than 500,000 doses, representing all of Gilead’s production for July and 90 percent in August and September.
“The United States has taken over access to most of the distribution of this drug, so there is nothing for Europe,” said Dr Andrew Hill in a statement at the University of Liverpool, reported The Guardian.
“President Trump has struck an astonishing deal to give Americans access to the first authorized treatment for COVID-19,” said US Secretary of Health Alex Azar.
“As much as possible, we want to make sure that any American patient who needs Remdesivir can receive it. The Trump administration is doing everything in its power to learn more about the treatments that save the lives of COVID-19 patients and to ensure access to them for the American people,” he added.
The drug is produced by the American pharmaceutical company Gilead, which has already set the price with which he will sell a dose to government companies in developed countries: $390, he writes Bloomberg. Six doses are needed to treat a patient, with a total cost of $2,340.
The agreement was announced, given that the pandemic situation in the US is critical.
The United States, the country most affected by the coronavirus pandemic, could reach 100,000 infections a day, warned the director of the Institute of Infectious Diseases, Anthony Fauci.
The doctor said he was extremely concerned about the situation: the United States had exceeded 40,000 daily infections and reached almost 2.7 million illnesses and 129,000 deaths.
The number of infections is rising in 36 US states, and California, Texas, Florida and Arizona have already suspended plans to ease restrictions.